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Abstract Cyanobactins are small cyclic peptides that are
produced by a diverse selection of cyanobacteria living in
symbioses as well as terrestrial, marine, or freshwater
environments. They include compounds with antimalarial,
antitumor, and multidrug reversing activities and potential
as pharmaceutical leads. Cyanobactins are produced
through the proteolytic cleavage and cyclization of precur-
sor peptides coupled with further posttranslational modifi-
cations such as heterocyclization, oxidation, or prenylation
of amino acids. Cyanobactin gene clusters encode two
proteases which cleave and cyclisize the precursor peptide
as well as proteins participating in posttranslational mod-
ifications. The bioinformatic mining of cyanobacterial
genomes has led to the discovery of novel cyanobactins.
Heterologous expression of these gene clusters provided
insights into the role of the genes participating in the
biosynthesis of cyanobactins and facilitated the rational
design of novel peptides. Enzymes participating in the
biosynthesis of cyanobactins may prove useful as catalysts
for producing novel cyclic peptides in the future. The recent
discovery of the cyanobactin biosynthetic pathway in
cyanobacteria extends our knowledge of their potential as
producers of interesting metabolites.
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Cyanobactins
Cyanobacteria are one of the most promising microbial
groups in the search for novel bioactive compounds. Low
molecular weight peptides containing a range of proteino-
genic and nonproteinogenic amino acids are a major class
of bioactive compounds produced by cyanobacteria (Burja
et al. 2001). A plethora of small cyclic or linear peptides
with a surprisingly high level of structural variation have
been reported from cyanobacteria (Welker and von Döhren
2006; Sivonen and Börner 2008). These peptides are
produced by both nonribosomal and ribosomal biosynthetic
pathways in cyanobacteria. The first nonribosomal path-
ways for cyanobacterial peptides were described in 2000
(Tillett et al. 2000; Rouhiainen et al. 2000) whereas the first
ribosomal pathway was shown in 2005 for the cyanobactin
patellamide (Schmidt et al. 2005).
Cyanobactin was proposed as a collective name for
cyclic peptides which contain heterocyclized amino acids or
isoprenoid amino acid derivatives (Donia et al. 2008a;
Schmidt and Donia 2009). Cyanobactins were initially
defined to contain oxazolines, thiazolines, or their oxidized
derivatives oxazoles and thiazoles (Fig. 1). This definition
was recently broadened to include cyclic peptides which
consist solely of proteinogenic amino acids (Leikoski et al.
2010). Isoprenoid amino acid derivatives are rare but found
for example in trunkamide, patellin, and anacyclamides
(Tables 1 and 3, Fig. 1).
Occurrence and chemical diversity of cyanobactins
More than a hundred cyanobactins have been identified
from symbiotic associations formed between cyanobacteria
and ascidians (Table 1) or from free-living cyanobacteria
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(Tables 2 and 3, Fig. 1). This makes cyanobactins one of
the largest classes of cyanobacterial peptides (Donia et al.
2006; Schmidt and Donia 2009). Cyanobactins identified
from filter-feeding organisms, such as ascidians and
sponges, usually contain from six to ten amino acids and
varying numbers and combinations of oxazoles, oxazolines,
thiazoles, and thiazolines. A few cyanobactins, such as
comoramides, contain prenylated amino acids, and ulithia-
cyclamides have disulfide bridges between two cysteine
amino acids (Table 1).
It is unclear if the cyanobactins are produced by the filter-
feeding organisms themselves, heterotrophic bacteria, or
cyanobacteria associated with these organisms (Table 1). Some
cyanobactins have now been verified to be produced by
cyanobacteria (Schmidt et al. 2005; Donia et al. 2006). The
biosynthetic origin of most of the analogous cyclic peptides
reported from cyanobacteria (Tables 2 and 3) is currently
unknown. To date, only ribosomal biosynthetic pathways
have been described to produce these cyclic peptides
(Schmidt et al. 2005; Donia et al. 2006, 2008a; Sudek et al.
2006; Ziemert et al. 2008b; Leikoski et al. 2010). However, a
nonribosomal peptide synthetase pathway could be an
alternative route for the biosynthesis of these compounds.
Cyanobacterial strains produce ribosomal cyanobactins
which contain heterocyclized amino acids (Table 2) and
also cyclic peptides which consist solely of unmodified
proteinogenic amino acids, occasionally with prenyl attach-
ments (Table 3). Cyanobactins which are found in by
cyanobacteria and contain heterocyclized amino acids range
in size from six to eleven amino acids (Table 2). Oxazoles
and thiazoles are common while oxazolines or thiazolines
occur with a lower frequency (Table 2). The cyanobactins
which lack heterocyclized amino acids vary in length from
seven to 20 amino acids (Table 2). Interestingly, a feature
uniting cyanobactins without heterocyclized amino acids in
addition to the occasional prenyl attachment is the
conserved presence of a proline residue (Table 3).
The biosynthetic genes for cyanobactin production have
been described in distantly related cyanobacteria Prochloron,
Trichodesmium, Microcystis, Nostoc, Lyngbya, and Ana-
baena (Schmidt et al. 2005; Donia et al. 2006, 2008a; Sudek
et al. 2006; Ziemert et al. 2008b; Leikoski et al. 2010;
Fig. 2). In addition, one of the protease genes responsible for
cleavage of the cyanobactin precursor peptide was shown to
be common among planktonic freshwater cyanobacteria and
present in 48 out of 132 strains studied (Leikoski et al. 2009).
These planktonic cyanobacteria included fresh and brackish
water strains from filamentous heterocystous (Anabaena,
Aphanizomenon, Nodularia), filamentous (Planktothrix), as
well as colony-forming (Microcystis and Snowella) cyano-
bacteria. The biosynthetic pathway appears to be relatively
common in these strains (Leikoski et al. 2009), but detailed
analysis of the gene clusters should be carried out and the
structure of the compounds remains to be identified.
Biosynthesis of cyanobactins
Cyanobactins are produced through the proteolytic cleavage
and head-to-tail (N–C) cyclization of precursor peptides
coupled with modification of specific amino acids as in
many other natural products (Oman and van der Donk
2010). The cyclic structure is formed via an amide linkage
of the α-carbonyl of C-terminal amino acid and α-amino
Fig. 1 The chemical structures
of a selection of cyanobactins.
Trunkamide was isolated from
L. patella, tenuecyclamide from
N. spongiaeforme, anacyclamide
from Anabaena, trichamide
from T. erythraeum, and ulithia-
cyclamide and patellamide from
Prochloron (originally from L.
patella). The corresponding
biosynthetic gene clusters are
shown in Fig. 2
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group of the N-terminal amino acid yielding a homodetic
cyclic peptide. In cyanobactin biosynthesis, the precursor
peptide directly encodes one or more cyanobactins flanked by
the putative recognition sequences at which the precursor
peptide is cleaved by two proteases (Schmidt et al. 2005; Lee
et al. 2009). Cyanobactin precursor peptides encode more
than one cyanobactin, and this could be a means to enhance
the levels of peptide production or represent a mechanism for
generating chemical diversity. The cyanobactin gene cluster
encodes two proteases demonstrated to be involved in the
cleavage of the precursor peptide and cyclization of the
cyanobactin (Lee et al. 2009). The PatA protease encoded in
the patellamide biosynthetic gene cluster was shown to
cleave the precursor peptide at the N-terminal recognition
sequence while the PatG protease cleaved the precursor peptide
at the C-terminal recognition sequence (Lee et al. 2009).
However, only the PatG protease was required for N–C
cyclization of the cyanobactins (Lee et al. 2009).
The cyanobactin biosynthetic genes encoded in gene
clusters are approximately 10 kb in size and contain
between 7 and 12 genes (Fig. 2). The gene order is not
strictly conserved (Fig. 2). However, most often, the
biosynthetic genes are organized as in the patellamide pat
gene cluster. All of the cyanobactin gene clusters contain
two proteases, which work in tandem, a short precursor
peptide as well as proteins involved in the maturation of the
cyanobactins. The cyanobactin gene clusters in Prochloron
are highly similar (Schmidt et al. 2005; Donia et al. 2006).
Thiazoles and oxazoles are formed through the hetero-
cyclization and subsequent oxidation of cysteine, serine,
and threonine amino acids. Cyanobactin gene clusters
typically contain a gene encoding a PatD homolog which
is predicted to heterocyclize cysteine, serine, and threonine
to thiazolines and oxazolines (Schmidt et al. 2005). A PatF
homolog is often encoded in cyanobactin gene clusters and
thought to be involved in the heterocyclization and/or
prenylation of cyanobactins (Schmidt and Donia 2009).
The oxidase domain of the bimodular PatG protein is
believed to catalyze the oxidation of thiazolines and
oxazolines to thiazoles and oxazoles (Schmidt et al.
2005). Intriguingly, PatB and PatC are encoded in nearly
all cyanobactin gene clusters but are nonessential, with
patellamides being produced by heterologous expression of
the pat gene cluster in Escherichia coli in the absence of the
patB and patC genes (Donia et al. 2006, 2008a).
Patellamides, lissoclinamides, ulithiacyclamides,
and patellins
Biologically active cyclic peptides have been reported from
Lissoclinum patella ascidians, but the biosynthesis of the
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obligate symbionts of these ascidians (Sings and Rinehart
1996). The findings of Schmidt and coworkers demonstrated
that the cyanobactin pathway was responsible for the produc-
tion of patellamide in symbiotic uncultured Prochloron spp. as
well as lissoclinamides, ulithiacyclamides, patellin, and the
anticancer drug candidate trunkamide (Schmidt et al. 2005;
Donia et al. 2006; Donia et al. 2008a). The cyanobactins
which are produced by Prochloron spp. are structurally
diverse and range in size from six to eight amino acids
(Table 1, Schmidt et al. 2005; Donia et al. 2006, 2008a).
Ascidians harbor amixture of symbioticProchloron strains.
The portion of the precursor peptide gene encoding the core
peptide in the cyanobactin gene clusters from Prochloron
spp. is hypervariable. Hence, a library of cyanobactins is
synthesized when multiple uncultivated Prochloron strains
are present in the tunicate (Donia et al. 2006).
Patellins and trunkamides produced by uncultured symbi-
otic Prochloron spp. contain prenylated amino acids (Donia
et al. 2008a). The prenylated cyanobactins do not have
oxazoles or thiazoles, only unoxidized forms of these hetero-
cyclized amino acids occur, and the oxidase domain of PatG is
missing in the patellin and trunkamide biosynthetic gene
cluster (Schmidt and Donia 2009). In addition, the prenylating
pathway encodes two PatF proteins whose roles are unclear,
and the prenylation is not fully understood at present
(Schmidt and Donia 2009). Ulithiacyclamides contain four
cysteines, two of which form a disulfide bridge and the other
two cysteines are heterocyclized to thiazoles (Table 1). Among
the more than hundred cyanobactins, disulfide bridges are
only found in ulithiacyclamides (Tables 1, 2, and 3).
Tenuecyclamides
Tenuecyclamides are hexapeptides containing two thiazoles
and an oxazole (Banker and Carmeli 1998, Table 2). A
cyanobactin pathway for the biosynthesis of tenuecyclamide
was characterized in an epilithic Nostoc spongiaeforme strain
(Fig. 2, Donia et al. 2008a). The tenuecyclamide ten gene
cluster has an identical gene organization to pat gene cluster as
the genes are transcribed to the same direction, and the gene
order is conserved. The TenE precursor peptide encodes four
copies of the core peptide amino acid sequences which form
tenuecyclamides A and C (Donia et al. 2008a). Tenuecycla-
mides A and B differ only in stereochemistry (Table 2).
Trichamide
Trichamide is cyclic 11 amino acid cyanobactin which
contains two thiazoles (Sudek et al. 2006). This cyanobac-
tin was discovered through genome mining of Trichodes-
mium erythraeum IMS101, a free-living, nitrogen-fixing
filamentous marine cyanobacterium (Schmidt et al. 2005;
Sudek et al. 2006). The tri gene cluster is 12.5 kb and
encodes 11 open reading frames (ORFs) with a bidirection-
al gene order for which only six genes have an assigned
function (Fig. 2, Sudek et al. 2006). The trichamide
precursor peptide encodes a single copy of the trichamide
core peptide flanked by the putative recognition sequences.
In contrast to Pat proteins, the oxidase and the protease
domains in Trichodesmium are encoded by separate genes
(Sudek et al. 2006).
Lyngbyabactins
A cyanobactin gene cluster has been also identified from
the genome of the marine Lyngbya aestuarii CCY9616
(Fig. 2, Donia et al. 2008a). The products of this gene
cluster, lyngbyabactins A and B, were predicted from the
precursor peptide LynE (Donia et al. 2008a). The peptides
Fig. 2 Cyanobactin gene clus-
ters published from seven dis-
tantly related cyanobacteria.
These gene clusters are typified
by genes encoding proteases
(yellow), a short precursor pep-
tide (red), proteins involved in
the maturation of the cyanobac-
tin (black), as well as conserved
and hypothetical open reading
frames (white)
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are predicted to include isoprenoid amino acid derivatives
(Donia et al. 2008a). However, lyngbyabactins A and B
have not yet been detected from L. aestuarii CCY9616. The
lyngbyabactin biosynthetic gene cluster has homologs of all
genes present in the pat gene cluster but it also contains five
other open reading frames which have no function assigned
(Donia et al. 2008a).
Microcyclamides and aerucyclamides
Microcyclamide is a cytotoxic cyclic hexapeptide reported
from the freshwater bloom-forming cyanobacterium Micro-
cystis aeruginosa NIES-298 (Ishida et al. 2000). The micro-
cyclamides 7806A and B of M. aeruginosa PCC 7806 were
later renamed as aerucyclamides, and the structures were
revised (Portmann et al. 2008a, b). Microcyclamides and
aerucyclamides are assembled via the cyanobactin biosyn-
thetic pathway in two strains ofM. aeruginosa NIES 298 and
PCC 7806 (Ziemert et al. 2008b; Portmann et al. 2008a, b).
The mca gene clusters have the same gene order as the pat
genes except for two additional open reading frames for
which no functions could be assigned (Fig. 2, Ziemert et al.
2008b). The McaE precursor peptide encodes two identical
copies of the microcyclamide core peptides in M. aeruginosa
NIES-298 (Ziemert et al. 2008b).
Anacyclamides
A variety of anacyclamides have been identified from strains
of the genus Anabaena (Leikoski et al. 2010, Table 3).
Anacyclamides consist of proteinogenic amino acids, and
some contain prenyl or geranyl groups through the posttrans-
lational modifications of specific amino acids. The acy gene
cluster in Anabaena sp. 90 encodes 11 ORFs, and it is
arranged in an eleven kb operon which is bidirectionally
transcribed as the trichamide gene cluster (Fig. 2). The gene
cluster differs from pat gene cluster in that there were no
homologs for all pat genes. Additionally, there were
hypothetical ORFs present in the acy gene cluster that were
absent in the pat gene cluster (Leikoski et al. 2010). The
precursor peptide AcyE encodes single copy of the
anacyclamide A10 (Fig. 1) flanked by putative recognition
sequences which differ substantially from other cyanobactin
precursors (Leikoski et al. 2010). The anacyclamide gene
cluster lacks a PatD homolog which agrees well with the
anacyclamide structure which has no posttranslationally
heterocyclized amino acids (Leikoski et al. 2010). The
AcyG protein lacks an oxidase domain which is consistent
with the absence of heterocyclized amino acids (Leikoski et
al. 2010). In anacyclamides, the length of the peptides
varies greatly which is achieved by expansion of the AcyE
precursor protein. Anacyclamides showed great amino acid
variation since only one proline was conserved (Table 3).
Bioactivities
The cyanobactins and cyclic peptides with analogous struc-
tures have various reported bioactivities (in detail, see Tables 1,
2, and 3). The diverse bioactivities are derived from versatile
structures, but all cyanobactins do not exhibit bioactivities in
the tests used or those have not been studied yet (Tables 1, 2,
and 3). Several of the cyanobacterial metabolites have been
found to be anticancer compounds, e.g., trunkamide (Salvatella
et al. 2003); some have multidrug reversing activities (Ogino
et al. 1996) as well as activities against tropical parasites such
as malaria-causing Plasmodium falciparum (Linington et al.
2007; Portmann et al. 2008b). In bacteria, many of the
ribosomally produced peptides are antibiotics or bactericides
produced to kill or inhibit growth of competing microbes
(Nolan and Walsh 2009). Cyanobacteria are photosynthetic
autotrophic organisms grazed by eukaryotic organisms. They
are believed to form mutualistic association with heterotrophic
bacteria, but this may not be always the case (Manage et al.
2000; Berg et al. 2009). Nostocyclamides for example have
been shown to contain anticyanobacterial activity (Todorova
et al. 1995; Jüttner et al. 2001). There are compounds isolated
from cyanobacteria with antibiotic (Ishida et al. 1997) or
antiviral (Boyd et al. 1997; Bokesch et al. 2003) effects,
leaving open the option that some of the cyanobactins may
prove to be antibiotic or antiviral compounds.
Analogous pathways
In addition to cyanobactins, another cyanobacterial peptide
class, microviridins, was recently shown to be ribosomally
produced in M. aeruginosa and Planktothrix agardhii, but
their biosynthetic machinery differs from that of cyanobac-
tins (Ziemert et al. 2008a; Philmus et al. 2008). These
compounds were originally thought to be products of
nonribosomal peptide biosynthesis. However, microviridins
are synthesized from precursor peptides that are converted
into tricyclic depsipeptides through the action of ATP grasp
ligases and a transporter peptidase (Ziemert et al. 2008a;
Philmus et al. 2008). The work of Philmus et al. (2008)
reported similar gene clusters in the genomes of Anabaena
variabilis, Nostoc punctiforme, and Nodularia spumigena
as well as in genomes of other bacteria.
The biosynthetic gene clusters encoding the production
pathway of ribosomal peptides with oxazoles and thiazoles
are present in a broad range of bacteria (Lee et al. 2008).
Bacteria distantly related to cyanobacteria are known to
produce bacteriocins by the posttranslational modification
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of gene-encoded precursor peptides, including microcins
and the lanthionine-containing lantibiotics of Gram-positive
bacteria (Jack et al. 1995; Jack and Jung 2000; Nolan and
Walsh 2009). Cyanobactin biosynthesis is analogous in
many ways to the biosynthesis of bacteriocins (Franz et al.
2007; Nolan and Walsh 2009). The leader-peptide-guided
biosynthesis is common in many ribosomally synthesized
natural products where the precursor peptide is synthesized
and cleaved, and in some cases the core peptide is
posttranslationally modified (Oman and van der Donk
2010). Bacteriocins can be also circularized as cyanobac-
tins, and some bacteriocins have similar posttranslational
modifications as cyanobactins for example thiazoles and
oxazoles (Jack and Jung 2000; Maqueda et al. 2008;
Martin-Visscher et al. 2009).
Many of cyanobacterial bioactive compound classes
are synthesized on nonribosomal peptide synthetases
(NRPS) or combined NRPS and polyketide synthases
(Welker and von Döhren 2006; Sivonen and Börner 2008).
However, the cyanobactins have been shown to be
produced by the posttranslational modification of the
gene-encoded precursor peptides (e.g., Schmidt et al.
2005; Donia et al. 2008a). The gene clusters responsible
for ribosomal peptide production are small compared to the
large nonribosomal peptide synthetase gene clusters. In
NRPS, variation in the chemical structure of the peptide is
achieved by utilization of more than 200 nonproteinogenic
amino acids (Nolan and Walsh 2009) whereas ribosomal
peptides are restricted to 20 proteinogenic amino acids
which may be posttranslationally modified. In NRPS, the
enzymes seem to have relaxed substrate specificity and thus
allow simultaneous production of a number of structural
variants in the same strain of a cyanobacterium (Welker and
von Döhren 2006).
Biotechnological aspects
The biotechnological exploitation of cyanobactins will
require detailed studies on the enzymes involved in the
biosynthesis as well as mechanisms of action of these
peptides. It is possible to express the cyanobactin gene
clusters in heterologous hosts (Schmidt et al. 2005; Donia
et al. 2006, 2008a; Leikoski et al. 2010). The small size of
the cyanobactin gene clusters and the expression of the
entire clusters in heterologous hosts will provide new
possibilities to create compound libraries and novel com-
pounds (Donia et al. 2006, 2008a). In the cyanobactin
pathway, heterologous expression gives options to study the
role of individual genes in biosynthesis as well as produce
novel peptides. The cyanobactin pathway was utilized in E.
coli to synthesize an engineered peptide eptidemnamide, a
cyclic peptide similar to an anticoagulant in clinical use
(Donia et al. 2006). This approach demonstrates a means to
exploit cyanobacterial pathways and produce novel com-
pounds by the rational design of peptides. The peptide-
precursor-directed synthesis allows manipulations directly
to the precursor gene and enables production of engineered
peptides in heterologous hosts (Oman and van der Donk
2010). In addition, the enzymes in the cyanobactin pathways
could be used as catalysts in aiding chemical synthesis of the
desired compounds. The work by Lee et al. (2009) not only
clarified the role of proteases in the cyanobactin biosynthesis
but demonstrated the potential of the enzyme as general
catalysts for cyclization of peptides. The technological
advantages of the PatG protease were that no energy is
required for the cleavage and cyclization, and also the
protease was proven to be tolerant of different substrate
lengths and sequences as long as the C-terminal recognition
sequence was present (Lee et al. 2009). This is important as
in synthetic peptide manufacture the head-to-tail cyclization
step restricts peptide production in bulk amounts.
It should be noted that whole-genome information has
already led to the discovery of cyanobactin biosynthesis as
well as several new compounds and compound classes,
e.g., patellamides (Schmidt et al. 2005), trichamide (Sudek
et al. 2006), and anacyclamides (Leikoski et al. 2010). The
increasing number of genome projects on cyanobacteria
and metagenomic studies (Schmidt and Donia 2009)
applied to various environments are likely to yield new
discoveries including diverse ribosomal pathways and
novel cyanobactins in the future.
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